Background Respiratory syncytial virus (RSV) is a major cause of acute lower respiratory
infection (ALRI) in young children aged< 5 years. Methods We aimed to identify the global …

Respiratory syncytial virus (RSV) infection is a leading cause of hospitalisation in early
childhood and palivizumab is the only licensed intervention for prevention. Palivizumab …

Background Respiratory syncytial virus (RSV) causes a considerable disease burden in
young children globally, but reliable estimates of RSV-related costs and health-related …

METHODS: Retrospective cohort study of previously healthy infants aged< 12 months with
bronchiolitis. Our primary outcome was that hospitalization occurred with EBST (ie …

Introduction: Respiratory syncytial virus (RSV) bronchiolitis is among the leading causes of
hospitalization in infants. Prophylaxis with palivizumab may reduce RSV infection, but its …

METHODS: We conducted a retrospective cohort study of previously healthy infants aged<
12 months with bronchiolitis. Our primary outcome was escalated care (ie, hospitalization …

Respiratory Syncytial Virus Bronchiolitis in Children up to... : Medicine Respiratory Syncytial
Virus Bronchiolitis in Children up to 5 Years of Age in Spain: Epidemiology and Comorbidities …

Objective Acute bronchiolitis is a common disorder of infants that often results in
hospitalization. Apart from supportive care, no therapy has been shown to influence the …

Objectives To identify the epidemiologic predictors and stratify the risk of critical care unit
(CCU) admission or death in bronchiolitis following emergency department discharge. This …

Aim Up to 3% of infants with bronchiolitis under 12 months of age are hospitalised, and up to
9% require intensive care. We evaluated the costs of bronchiolitis hospitalisation, with a …